<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Plasma insulin in healthy subjects shows regular oscillations, which are important for the hypoglycemic action of the hormone </plain></SENT>
<SENT sid="1" pm="."><plain>In individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, these regular variations are altered, which has been implicated in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The origin of the change is unknown, but derangement of the islet secretory pattern has been suggested as a contributing cause </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we show the dynamics of insulin release from individually perifused islets isolated from three subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Insulin release at 3 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> was 10.5 +/- 4.5 pmol.g(-1).s(-1) and pulsatile (0.26 +/- 0.05 min(-1)) </plain></SENT>
<SENT sid="5" pm="."><plain>In islets from one subject, 11 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> transiently increased insulin release by augmentation of the insulin pulses without affecting the frequency </plain></SENT>
<SENT sid="6" pm="."><plain>Addition of 1 mmol/l <z:chebi fb="0" ids="27999">tolbutamide</z:chebi> did not increase insulin release </plain></SENT>
<SENT sid="7" pm="."><plain>In islets from the remaining subjects, insulin release was not affected by 11 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="27999">Tolbutamide</z:chebi> transiently increased insulin release in islets from one subject </plain></SENT>
<SENT sid="9" pm="."><plain>Insulin release from four <z:mpath ids='MPATH_458'>normal</z:mpath> subjects at 3 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> was 4.3 +/- 0.8 pmol.g(-1).s(-1) and pulsatile (0.23 +/- 0.03 min(-1)) </plain></SENT>
<SENT sid="10" pm="."><plain>At 11 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin release increased in islets from <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="27999">Tolbutamide</z:chebi> further increased insulin release in islets from two subjects </plain></SENT>
<SENT sid="12" pm="."><plain>It is concluded that islets from the three individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> release insulin in pulses </plain></SENT>
<SENT sid="13" pm="."><plain>The impaired secretory response to <z:chebi fb="105" ids="17234">glucose</z:chebi> may be related to impaired metabolism before <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> degradation of the sugar </plain></SENT>
</text></document>